Biodegradable Micelles for Liver-Targeted Gene Delivery
Biodegradable Micelles for Liver-Targeted Gene Delivery
批准号:
8019090
负责人:
Hai-Quan Mao
金额:
$39.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2013-01-31
关键词:
BindingBiocompatibleBiocompatible MaterialsBiologicalBloodBlood CirculationBuffersCellsCellular biologyCharacteristicsClinical SciencesComplexDNADNA BindingDiscontinuous CapillaryDiseaseDisorder by SiteDisulfidesDrug FormulationsEncapsulatedExhibitsFoundationsFutureGalactoseGene DeliveryGene ExpressionGene TargetingGene TransferGenesHealthHemophilia AHepatocyteHereditary DiseaseHistocompatibilityImidazoleIn VitroInfusion proceduresInheritedInterferonsIntracellular TransportIntravenousKineticsKupffer CellsLengthLibrariesLiverLiver diseasesLuciferasesMalignant NeoplasmsMalignant neoplasm of liverMediatingMedicineMetabolicMethodsMicellesMolecularPhysiologicalPolymer ChemistryPolymersPropertyProteinsRattusResearchSeriesSiteStructureSurfaceSystemSystemic diseaseTherapeuticTissuesToxic effectTransfectionTransgenesViral hepatitisVirus Diseasesbiliary tractbiomaterial compatibilitycholangiocyteclinical applicationcopolymercrosslinkcytotoxicitydesignextracellulargene therapyimprovedin vivointravenous injectionmeetingsnanoparticlenovelpolycationprotein expressionsecretory proteintargeted deliverytraffickingtransgene expressionuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall objective of this proposal is to develop biocompatible, biodegradable and self- assembling copolymer/DNA micelles to achieve efficient liver-targeted gene delivery. Liver is a critically important target for gene medicine applications because of the access of the transgene product to systemic circulation, and because it is the site of many metabolic genetic disorders, viral infection and malignancies. At present, the full potential of liver-targeted gene transfer is hindered by a lack of safe and efficient gene carriers. Polymeric micelles with a DNA/polycation complex core and a hydrophilic corona represent a promising carrier for liver-targeted gene delivery. These DNA-encapsulating micelles exhibit several desirable features that favor liver- targeted gene delivery, such as small size (80-100 nm), reduced interaction with biological components, prolonged circulation in blood, and low toxicity. Novel PEG-b-PPA/DNA micelles exhibit high DNA binding capacity, in vitro transfection efficiency, low cytotoxicity and good tissue biocompatibility. In this study, we will (1) synthesize and characterize a mini-library of PEG-b-PPA/DNA micelles with improved complex stability, colloidal stability, intracellular DNA release, endosomal escape, and hepatocyte-targeting ability; (2) characterize the transfection efficiency and cytotoxicity in rat primary hepatocytes, Kupffer cells and normal rat cholangiocytes for this series of structurally distinct copolymers/micelles, and correlate with micelle structures; (3) optimize the administration parameters to achieve efficient liver gene expression for both a non-secretory protein (luciferase) and a secretory protein (interferon-a2b). This will demonstrate the broad utility of this delivery strategy for expression of proteins intended for systemic distribution and for localized liver-specific diseases. Mechanistic studies will be performed in vitro and in vivo to understand the extracellular and intracellular transport of the micelles. This study integrates expertise in polymer chemistry, biomaterial design, molecular/cell biology and clinical sciences. It represents a systematic design and optimization of gene delivery strategies at multiple levels. This study will lay the foundation for future clinical application of polymeric micelles for liver-targeted gene therapy. PUBLIC HEALTH RELEVANCE The overall objective of this proposal is to develop safe and efficient non-viral nanoparticle carriers for gene delivery to the liver. Should this proposed study be successful, these new gene carriers will find wide clinical applications for treating inherited and metabolic liver diseases, liver cancer, viral hepatitis, and systemic diseases, like hemophilia A and B.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/adma.201202932
发表时间:
2013-01-11
期刊:
ADVANCED MATERIALS
影响因子:
29.4
作者:
[Jiang, Xuan, Qu, Wei, Pan, Deng, Ren, Yong, Williford, John-Michael, Cui, Honggang, Luijten, Erik, Mao, Hai-Quan]
通讯作者:
Mao, Hai-Quan
DOI:
10.1021/acsbiomaterials.5b00080
发表时间:
2015-06-08
期刊:
ACS biomaterials science & engineering
影响因子:
5.8
作者:
[We Z, Ren Y, Williford JM, Qu W, Huang K, Ng S, Mao HQ, Luijten E]
通讯作者:
Luijten E
DOI:
10.1021/bm1009574
发表时间:
2010-12-13
期刊:
BIOMACROMOLECULES
影响因子:
6.2
作者:
[Ren, Yong, Jiang, Xuan, Pan, Deng, Mao, Hai-Quan]
通讯作者:
Mao, Hai-Quan
A nanofiber-hydrogel composite plug for perianal fistula repair
-
批准号:10607324
-
项目类别:
-
资助金额:$65.18万
-
财政年份:2023
-
负责人:Hai-Quan Mao
-
依托单位:
Biomimetic Matrix for Ex Vivo and In Vivo Activation of T Cells
-
批准号:10608176
-
项目类别:
-
资助金额:$47.94万
-
财政年份:2020
-
负责人:Hai-Quan Mao
-
依托单位:
Biomimetic Matrix for Ex Vivo and In Vivo Activation of T Cells
-
批准号:10205064
-
项目类别:
-
资助金额:$46.99万
-
财政年份:2020
-
负责人:Hai-Quan Mao
-
依托单位:
Biomimetic Matrix for Ex Vivo and In Vivo Activation of T Cells
-
批准号:10392463
-
项目类别:
-
资助金额:$47.94万
-
财政年份:2020
-
负责人:Hai-Quan Mao
-
依托单位:
Training and Dissemination
-
批准号:10645135
-
项目类别:
-
资助金额:$10.76万
-
财政年份:2019
-
负责人:Hai-Quan Mao
-
依托单位:
Training and Dissemination
-
批准号:10436874
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2019
-
负责人:Hai-Quan Mao
-
依托单位:
Training and Dissemination
-
批准号:9790440
-
项目类别:
-
资助金额:$13.87万
-
财政年份:2019
-
负责人:Hai-Quan Mao
-
依托单位:
Training and Dissemination
-
批准号:10223296
-
项目类别:
-
资助金额:$10.7万
-
财政年份:2019
-
负责人:Hai-Quan Mao
-
依托单位:
Promote Organization and Integration of Regenerated Neurons from Transplanted Human Neural Stem Cells
-
批准号:9392271
-
项目类别:
-
资助金额:$20.44万
-
财政年份:2017
-
负责人:Hai-Quan Mao
-
依托单位:
Nanoparticle Delivery of DNA Vaccine Against Zika Virus
-
批准号:9379639
-
项目类别:
-
资助金额:$20.43万
-
财政年份:2017
-
负责人:Hai-Quan Mao
-
依托单位:
Directed In Vivo Differentiation of Neural Stem Cells for Repair of Brain Lesion
-
批准号:8824696
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2014
-
负责人:Hai-Quan Mao
-
依托单位:
Delivery of Shaped siRNA Nanoparticles by Retrograde Intrabiliary Infusion
-
批准号:8285119
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2012
-
负责人:Hai-Quan Mao
-
依托单位:
Delivery of Shaped siRNA Nanoparticles by Retrograde Intrabiliary Infusion
-
批准号:8448579
-
项目类别:
-
资助金额:$23.2万
-
财政年份:2012
-
负责人:Hai-Quan Mao
-
依托单位:
Shape Control and Transfection of Self-assembled Polymer-DNA Nanoparticles
-
批准号:8244219
-
项目类别:
-
资助金额:$24.68万
-
财政年份:2011
-
负责人:Hai-Quan Mao
-
依托单位:
Shape Control and Transfection of Self-assembled Polymer-DNA Nanoparticles
-
批准号:8399009
-
项目类别:
-
资助金额:$18.42万
-
财政年份:2011
-
负责人:Hai-Quan Mao
-
依托单位:
The Johns Hopkins Cancer Nanotechnology Training Center
-
批准号:8726937
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2010
-
负责人:Hai-Quan Mao
-
依托单位:
The Johns Hopkins Cancer Nanotechnology Training Center
-
批准号:8548285
-
项目类别:
-
资助金额:$28.98万
-
财政年份:2010
-
负责人:Hai-Quan Mao
-
依托单位:
Biodegradable Micelles for Liver-Targeted Gene Delivery
-
批准号:7913864
-
项目类别:
-
资助金额:$8.61万
-
财政年份:2008
-
负责人:Hai-Quan Mao
-
依托单位:
Biodegradable Micelles for Liver-Targeted Gene Delivery
-
批准号:7591157
-
项目类别:
-
资助金额:$25.52万
-
财政年份:2008
-
负责人:Hai-Quan Mao
-
依托单位:
Biodegradable Micelles for Liver-Targeted Gene Delivery
-
批准号:7466181
-
项目类别:
-
资助金额:$27.05万
-
财政年份:2008
-
负责人:Hai-Quan Mao
-
依托单位:
海外基金